Emergent BioSolutions Awarded Contract to Supply US Military With Anthrax Vaccine

The US Department of Defense awarded Emergent BioSolutions Inc. with a contract worth up to $235.8 million to supply all branches of the US military with BioThrax (Anthrax Vaccine Adsorbed) for use as pre-exposure prophylaxis against anthrax disease.

Leave a Reply

Your email address will not be published. Required fields are marked *